首页> 外文OA文献 >Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non–Small Cell Lung Cancer

【2h】

Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non–Small Cell Lung Cancer

机译：Carboplatin / Pemetrexed对没有贝伐单抗的比较有效性，用于晚期非小细胞肺癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stephen J. Bagley; Suzanna Talento; Nandita Mitra; Neal J. Meropol; Roger B. Cohen; Corey J. Langer; Anil Vachani;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin plus Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non-Small-Cell Lung Cancer [J] . Zinner Ralph G., Obasaju Coleman K., Spigel David R., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第1期

机译：释放：随机，开放标签，第一线Pemetrexed Plus Carboplatin的第三阶段研究，然后进行维持培养型Pemetrexed与PACLitaxel Plus Carboplatin Plus Bevacizumab，然后在患者中进行维护贝伐单抗，患者患者先进的非小细胞肺癌
2. PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin plus Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non-Small-Cell Lung Cancer [J] . Zinner Ralph G., Obasaju Coleman K., Spigel David R., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015,第1期

机译：方案：对于晚期非鳞状非小细胞肺癌患者，一线培美曲塞加卡铂联合维持培美曲塞与紫杉醇加卡铂+贝伐单抗联合贝伐珠单抗治疗的一线随机，开放标签III期研究
3. Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology. [J] . Zinner RG, Saxman SB, Peng G, Clinical lung cancer . 2010,第5期

机译：对于非鳞癌晚期非小细胞肺癌患者，进行培美曲塞/卡铂，维持培美曲塞与紫杉醇/卡铂/贝伐单抗的随机试验的治疗原理和研究设计。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. PRONOUNCE: Randomized Open-Label Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer [O] . Ralph G. Zinner, Coleman K. Obasaju, David R. Spigel, -1

机译：代名词：晚期非鳞状非小细胞肺癌患者一线培美曲塞+卡铂联合维持培美曲塞与紫杉醇+卡铂+贝伐单抗+贝伐珠单抗一线治疗的随机开放标签III期研究
7. PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer [O] . Zinner Ralph G., Obasaju Coleman K., Spigel David R., 2015

机译：方案：对于晚期非鳞状非小细胞肺癌患者，一线培美曲塞+卡铂联合维持培美曲塞与紫杉醇+卡铂+贝伐单抗联合贝伐珠单抗治疗的一线随机，开放标签，III期研究

Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non–Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅